President Trump on Friday announced that over 100 prescription medications would be added to his administration’s direct-to-consumer drug platform, TrumpRx, the second expansion of the initiative in as many months.
“I am pleased to announce that TrumpRx.gov is adding another 160 Prescription Drugs, at highly discounted prices, for a new total of over 800 of the most commonly-used Prescription Drugs,” Trump wrote on Truth Social.
“TrumpRx.gov will now provide clear, transparent, and DISCOUNTED offerings for FOUR OUT OF FIVE of every prescription filled by Americans,” the president added.
TrumpRx debuted in February with 43 branded prescription drugs, offering medications that treat conditions such as asthma, infertility and obesity to consumers at varying discounted rates. The platform now features two lists of medications, one for branded medications called “presidential deals” and another for generic drugs called “standard prices.”
It was built to facilitate Trump’s “most favored nation” (MFN) policy, which is designed to lower the cost of prescription drugs for U.S. consumers by dictating that drugmakers cannot charge a price for a specific brand-name drug higher than the lowest net price paid by other developed nations.
Health and Human Services Secretary Robert F. Kennedy Jr. previously asserted that the U.S. had been paying two to four times as much for the medications as other countries, a disparity the administration is working to fix.
Trump has often bragged about MFN, saying in his State of the Union address earlier this year that he has been able to do what other presidents “never could.” On Friday, he claimed the policy had saved Americans more than $400 million since the launch of TrumpRx.
“Of course, Most Favored Nations would not be possible without my use of TARIFFS, which are getting other Countries to ‘pay up’ instead of relying on American Patients getting ripped off, as they were for decades until I ordered an immediate ‘stop’ to this very unfair and, frankly, foolish situation,” the president wrote online.
Friday’s announcement came just weeks after billionaire investor Mark Cuban joined Trump at the White House for the rollout of 600 new drugs on the platform. Cuban said in April that his own discount drug platform, Cost Plus Drugs, was working with TrumpRx to integrate its medication lists.
“Republicans like cheap drugs, too. Independents like cheap drugs, too. Democrats like cheap drugs too,” the investor told Fox News at the time. “So that’s, that’s the mission, to make it inexpensive, starting with medications, and then going across the board to all healthcare.”